Graham-Field
This article was originally published in The Gray Sheet
Executive Summary
"Debtor-in-possession" credit facility for up to $38.8 mil. is secured following the filing of a voluntary Chapter 11 bankruptcy petition in Delaware federal court. The financing will provide the medical/surgical supply maker and distributor with sufficient liquidity to pay suppliers for "post-petition" goods and services, meet payroll, and carry it through completion of its debt restructuring, the firm says. The bankruptcy petition coincides with the resignations of John McGregor as president and CEO, and of Robert Gluck as chief financial officer. David Hilton was named to replace McGregor. Hilton is known as a turn-around specialist and formerly headed J.E. Morgan Knitting Mills. Rothschild, Inc. has been retained to provide investment-banking services
You may also be interested in...
Graham-Field Health Products, Inc.
Replacement $35 mil. "debtor-in-possession" financing agreement with Congress Financial Corporation closes April 17. The new financing arrangement replaces the current DIP loan serviced by IBJ Whitehall Business Credit Corporation, secured following a Chapter 11 bankruptcy filing in Delaware federal court, and includes more favorable terms (1"The Gray Sheet" Jan. 10, p. 10). "It is obvious that the financial community has strong faith in the company's ability to emerge from its Chapter 11 voluntary bankruptcy position as an on-going concern," CEO David Hilton commented
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.